the role of checkpoint inhibitors in classical hodgkin lymphoma
Published 2 years ago • 1.3K plays • Length 2:07Download video MP4
Download video MP3
Similar videos
-
1:40
checkpoint inhibitors in hodgkin lymphoma
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
2:11
strategies used to enhance checkpoint inhibition in hodgkin lymphoma
-
1:10
checkmate study and the role of nivolumab in hodgkin lymphoma
-
6:16
overview of novel restore and target treatment approach to classical hodgkin lymphoma
-
4:38
advocating for hodgkin lymphoma care: jenny's immunotherapy story
-
6:24
tnb-486: interim results of a cd19/cd3 t-cell engager in r/r follicular lymphoma
-
10:43
immunotherapy and lymphoma treatment
-
0:37
immune checkpoint inhibitors: shaping the future of lymphoma
-
1:14
pd-l1 inhibitors in r/r hodgkin lymphoma
-
1:27
the promise of novel checkpoint inhibitors for the treatment of hl
-
1:58
outcomes of patients with hodgkin lymphoma undergoing allohsct after pembrolizumab therapy
-
4:40
engraftment syndrome following asct in patients with checkpoint inhibitor treated hodgkin lymphoma
-
1:19
the role of chemotherapy in hodgkin lymphoma
-
1:37
the role of ctdna in hodgkin lymphoma
-
3:51
novel developments in relapsed/refractory hl: checkpoint inhibitors, bispecifics and car-t cells
-
3:30
determining effective combinations of immune checkpoint inhibitors for lymphoma
-
1:27
diagnosis and risk stratification in hodgkin lymphoma: updates and novel approaches
-
1:51
checkpoint inhibition in the treatment of mpns
-
2:17
the impact of checkpoint inhibitor-based salvage regimens in patients with r/r hl undergoing autosct
-
2:34
r/r lymphoma: checkpoint blockade and transplantation
-
1:09
the changing role of allosct in dlbcl in the era of novel agents